| [1] |
Jemal A, Bray F, Center MM, et al. Global Cancer Statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90.
|
| [2] |
Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease[J].N Engl J Med,2000, 34 2(18):1350-8.
|
| [3] |
Yiu GK, Chan WY, Ng SW, et al. SPARC(secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells[J] Am J Pathol, 2001, 159(2): 609-22.
|
| [4] |
Chlenski A,Cohn SL.Modulation of matrix remodeling by SPARC in neoplastic progression[J].Semin Cell Dev Biol,2010,21(1): 55 -65.
|
| [5] |
Brune K,Hong SM,Li A,et al.Genetic and epigenetic alterations of familial pancreatic cancers[J]. Cancer Epidemiol Biomarker Prev, 20 08, 17(12) : 3536-42.
|
| [6] |
Prada F, Benedetti LG，Bravo AI, et al. SPARC endogenous level，rather than fibroblast-produced SPARC or stroma reorganization induced by SPARC, is responsible for melanoma cell growth[J]. J Invest Dermatol, 2007, 127(11): 2618-28.
|
| [7] |
Yang E,Kang HJ,Koh KH,et al.Frequent inactivation of SPARC by promoter hypermethylation in colon cancers[J].Int J Cancer,2007, 12 1(3): 567-75.
|
| [8] |
Bull Phelps SL,Carbon J,Miller A,et al. Secreted protein acidic and rich in cysteine as a regulator of murine ovarian cancer growth and chemosensitivity[J].Am J Obstet Gynecol,2009,200(2):180. e1-7.
|
| [9] |
Suzuki M,Hao C,Takahashi T,et al. Aberrant methylation of SPARC in human lung cancers[J].Br J Cancer,2005,92(5):942-8.
|
| [10] |
Arends JW.Molecular interactions in the Vogelstein model of colorectal carcinoma[J]. J Pathol,2000,190(4):412-6.
|
| [11] |
Wang XD,Zhan ZL.Advanced reserch on TGF-beta and tumor TGF-beta and its receptor and the research progress of tumor[J]. Zhongguo Zhong Liu Lin Chuang, 2005, 32(17)：1016-20. [王旭 东, 战忠利. TGF-β及其受体与肿瘤的研究进展[J]. 中国肿瘤临 床, 2005, 32(17):1016-20.]
|
| [12] |
Dunning AM，Ellis PD，McBride S, et al. A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer[J]. Cancer Res,2003,63 (10):2610-5.
|
| [13] |
Liu SP, Dong WG, Luo HS, et al. Determination and clinical signifi cance of serum level of transforming growth factor-beta 1 in patients with colorectal cancer[J]. Wuhan Da Xue Xue Bao(Yi Xue Ban),2009,30(5):640-3.[刘少平,董卫国,罗和生,等. 结直肠 癌患者血清转化生长因子β1含量检测及临床意义[J]. 武汉大学 学报(医学版), 2009, 30(5) : 640-3.]
|
| [14] |
Muinelo-Romay L,Colas E,Barbazan J,et al.High-risk endometrial carcinoma profiling identifies TGF - β1 as a key factor in the initiation of tumor invasion[J]. Mol Cancer Ther, 2011, 10 (8) : 13 57-66.
|
| [15] |
Wu XT, Zhou SZ, Mo JM, et al. Determination and clinical significance of HIF-1α,VEGF and TGF-β1 expression in nonsmall cell lung cancinoma[J]. Zhongguo Ai Zheng Fang Zhi Za Zhi, 2013, 5(1):46-9. [吴新天, 周韶璋, 莫娟梅, 等. HIF-1α、 VEGF和TGF-β1在非小细胞肺癌中的表达及其临床意义[J]. 中 国癌症防治杂志, 2013, 5(1):46-9.]
|
| [16] |
He XR,Liu X,Huang YF.Expression of TGF-β1 in Lung Cancer Tissue and their Biological Significance[J].Chuan Bei Yi Xue Yuan Xue Bao,2010,25(5):403-5.[何欣蓉,刘馨,黄一凡.转化生长 因子β1在肺癌中的表达和意义[J].川北医学院学报,2010,25(5): 40 3-5.]
|
| [17] |
Rivera LB,Brekken RA. SPARC promotes pericyte recruitment via inhibition of endoglin-dependent TGF-β1 activity[J].J Cell Biol, 20 11,193(7):1305-19.
|
| [18] |
Tang MJ, Tai IT. A novel interaction between procaspase 8 and SPARC enhances apoptosis and potentiates chemotherapy sensitivity in colorectal cancers[J].J Biol Chem,2007, 28 2(47):34457-67.
|
| [19] |
Said N, Frierson HF Jr, Chernauskas D, et al.The role of SPARC in the TRAMP model of prostate carcinogenesis and progression[J]. Oncogene,2009,28(39):3487-98.
|
下载:
